Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Evaluating Daratumumab Effectiveness in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis of Clinical Outcomes and Prognostic Indicators

Vedant Shah, Bolivia Crocete Aloysia Fernandes, Muhammad Ashar Ali, Abhi Shah, Kaushal Patel, Aditya Mansabdar, Arya Alla, Viraj Panchal, Pramil Cheriyath

Blood (2024) 144 (Supplement 1): 7071.

https://doi.org/10.1182/blood-2024-209400

Published: 2024

Journal Articles

Comparison of Drugs Used for Prophylaxis in Hemophilia a or B with Inhibitors: A Systematic Review and Frequentist Network Meta-Analysis of Randomized Clinical Trials

Muhammad Ashar Ali, Wajeeha Aiman, Shammas Bajwa, Faiz Anwer

Blood (2024) 144 (Supplement 1): 5488.

https://doi.org/10.1182/blood-2024-211537

Published: 2024

Journal Articles

Impact of Daratumumab in Transplant Eligible/Ineligible Patients with Newly Diagnosed Multiple Myeloma: An Updated Meta-Analysis of Phase-III Trials

Bolivia Crocete Aloysia Fernandes, Vedant Shah, Muhammad Ashar Ali, Abhi Shah, Makarand Madine, Mounika Gottumukkala, Sucharitha Pandeti, Safa Syed, Vinod Nookala

Blood (2024) 144 (Supplement 1): 6987.

https://doi.org/10.1182/blood-2024-209494

Published: 2024

Journal Articles

CAR-T Cell Therapy Vs. Standard of Care for B-Cell Lymphoma: A Systematic Review and Meta- Analysis of Updated Results of Clinical Trials

Wajeeha Aiman, Muhammad Ashar Ali, Vasudha Maddukuri, Dennis Nana Asah Mensah, Shammas Bajwa, Astha Upadhyaya, Muhammad Yasir Anwar, Bader Al Omour, Gunwant Guron, Hamid Shaaban, Michael Maroules

Blood (2023) 142 (Supplement 1): 6239.

https://doi.org/10.1182/blood-2023-190523

Published: 2023

Journal Articles

Efficacy and Safety of Polatuzumab Vedotin in Follicular Lymphoma: A Systematic Review of Clinical Trials

Samer Jumean, Wajeeha Aiman, Murad Qirem, Osama Alkhlaifat, Muhammad Ashar Ali, Hamid Shaaban, Gunwant Guron, Bader Al Omour, Amr Ramahi, Nooredeen Isbeih

Blood (2023) 142 (Supplement 1): 6869.

https://doi.org/10.1182/blood-2023-188087

Published: 2023

Journal Articles

Effectiveness and Tolerability of ICE Combinations in Relapsed/Refractory Hodgkin's Lymphoma; A Systematic Review of Clinical Trials

Wajeeha Aiman, Venkata Sireesha Chemarthi, Muhammad Ashar Ali, Monique Prince, Yashwitha Sai Pulakurthi, Laura Hernandez, Hamid Shaaban, Michael Maroules, Gunwant Guron

Blood (2023) 142 (Supplement 1): 6196.

https://doi.org/10.1182/blood-2023-188121

Published: 2023

Journal Articles

Efficacy and Safety of FLT-3 Inhibitors in Newly Diagnosed FLT-3 Mutated AML Patients: A Systematic Review of Clinical Trials

Muhammad Ashar Ali, Bader Al Omour, Wajeeha Aiman, Nibras Yar khan, Sahar Memar Montazerin, Himaja Dutt Chigurupati, Ayushi Mohan, Muhammad Yasir Anwar, Gunwant Guron, Michael Maroules, Hamid Shaaban

Blood (2023) 142 (Supplement 1): 5847.

https://doi.org/10.1182/blood-2023-189625

Published: 2023

Journal Articles

Efficacy and Safety of Viral Vector Based Gene Therapy in Patients with Hemophilia a: A Systematic Review

Wajeeha Aiman, Syeda Hafsa Kazmi, Memoona Saeed, Muhammad Imran Khan, Zainab Omar, Muhammad Suleman, Taimoor Jamil, Mahak Khadija Bhatti, Sigmone Khalid Butt, Hina Zubair, A. Supraja, Maha Zafar, Yusra Arooj, Muhammad Ashar Ali

Blood (2022) 140 (Supplement 1): 12992–12993.

https://doi.org/10.1182/blood-2022-158105

Published: 2022

Journal Articles

Efficacy and Safety of IDH Inhibitors in AML: A Systematic Review of Clinical Trials

Muhammad Ashar Ali, Shadma Fatima, Ashish Nepal, Huda Khan, Mahak Khadija Bhatti, Memoona Saeed, Rabiya Niaz, Rooma Habib, Zainab Omar, Zubair Shafique, Muhammad Imran Khan, Muhammad Hassab, Wajeeha Aiman

Blood (2022) 140 (Supplement 1): 11763–11764.

https://doi.org/10.1182/blood-2022-158821

Published: 2022

Journal Articles

Efficacy and Safety of Nelarabine in Different Age Groups with T-Cell Hematological Malignancies: A Systematic Review of Clinical Trials

Wajeeha Aiman, Zainab Omar, Muhammad Saad Anwar, Sarah Sarwat Uzma Munawar, Sumaiya Asfund, Yusra Arooj, Shadma Fatima, Hina Zubair, Huda Khan, Rabiya Niaz, Taimoor Jamil, Ayesha Anwar, Muhammad Ashar Ali

Blood (2022) 140 (Supplement 1): 11696–11697.

https://doi.org/10.1182/blood-2022-167981

Published: 2022

Journal Articles

Efficacy and Safety of Tyrosine Kinase Inhibitors in the Treatment of Relapsed/Refractory Immune Thrombocytopenia

Muhammad Ashar Ali, Memoona Saeed, A. Supraja, Maha Zafar, Ashish Nepal, Muhammad Suleman, Rooma Habib, Sana Rashid, Sumaiya Asfund, Muhammad Abdul Basit, Hafsa Zahoor, Sviatoslav Kosach, Aqsa Anwar, Wajeeha Aiman

Blood (2022) 140 (Supplement 1): 8408–8409.

https://doi.org/10.1182/blood-2022-158236

Published: 2022

Journal Articles

Efficacy and Safety of Chimeric Antigen Receptor T Cell Therapy in Chronic Lymphocytic Leukemia: A Systematic Review

Rooma Habib, Wajeeha Aiman, Ishan Garg, Rabiya Niaz, Sigmone Khalid Butt, Memoona Saeed, Hina Zubair, Tooba Kashif, Huda Khan, Mahwish Farrukh, Madiha Naveed, Nayha Tahir, Aqsa Fatima, Muhammad Ashar Ali

Blood (2021) 138 (Supplement 1): 4822.

https://doi.org/10.1182/blood-2021-153595

Published: 2021

Journal Articles

Efficacy and Safety of Recombinant Thrombombomodulin for the Prophylaxis of Vaso-Occlusive Complications in Allogenic Hematopoietic Stem Cell Transplantation : A Systematic Review and Meta-Analysis

Richi Kashyap, MD, Muhammad Ashar Ali, MD, Taaha Muddassir Mirza, MBBS, Anum Javaid, MD, Aniqa Raheem, MBBS, Rohail Gul, MBBS, Muhammad Tayyeb, MD, Muhammad Yasir Anwar, Abdul Jabbar Dar, MD, Qasim Khurshid, MD, Karun Neupane, MBBS,MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-136909

Published: 2020

Journal Articles

Efficacy and Safety of Amlodipine in Preventing Myocardial Iron Overload in Patients with Transfusion-Dependent Thalassemia Major : A Systematic Review and Meta-Analysis

Richi Kashyap, MD, Muhammad Ashar Ali, MD, Saad Ullah Malik, MD, Farhan Khalid, MBBS, Ali Jaan, MD, Awais Khalid, MBBS, Abdul Jabbar Dar, MD, Qasim Khurshid, MD, Karun Neupane, MBBS,MD, Mobeen Zaka Haider, MDMBBS, Syed Maaz Abdullah, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 48–49.

https://doi.org/10.1182/blood-2020-137713

Published: 2020

Journal Articles

Anti-Thymocyte Globulin (ATG) for Prophylaxis of Severe Graft Vs. Host Disease after Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis

Muhammad Ashar Ali, MD, Muhammad Yasir Anwar, Sobia Aamir, MDFCPS, Saad Ur Rahman, MBBS, Richi Kashyap, MD, Sana Irfan Khan, MD, Usman Ali Akbar, MBBS, Anum Waqar, MBBS, Anam Khan, Wajeeha Aiman, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-135950

Published: 2020

Journal Articles

Safety and Efficacy of Salvage Therapies for Relapse/Refractory AML/MDS after First Allogeneic Hematopoietic Stem Cell Transplant: A Systematic Review

Farwah N. Fatima, MBBS, Muhammad Ashar Ali, MD, Anum Javaid, MD, Rimsha Ali, Aqsa Mumtaz, MBBS, Wajeeha Aiman, MD, Nayab Mirza, MD, Sana Khan, MBBS, Hamza Hashmi, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-139264

Published: 2020

Journal Articles

Ixazomib Based Regimens in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials

Anum Javaid, MD, Faryal Razzaq, MBBS, Muhammad Ashar Ali, MD, Muhammad Abu Zar, MD, Atif Sohail, MD MBBS, Ahmad Iftikhar, MD, Rana Usman, MD, Muhammad Yasir Anwar, Hamza Hassan, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 35.

https://doi.org/10.1182/blood-2020-141620

Published: 2020

Journal Articles

Efficacy and Safety Profile of Ixazomib Based Regimens in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis of Clinical Trials

Ahmad Iftikhar, MD, Muhammad Ashar Ali, MD, Anum Javaid, MD, Muhammad Abu Zar, MD, Atif Sohail, MD MBBS, Faryal Razzaq, MBBS, Rana M Usman, MD MBBS, BSc, Muhammad Yasir Anwar, Hamza Hassan, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-141984

Published: 2020

Journal Articles

Risk of Thyroid Dysfunctions with Use of Immune Checkpoint Inhibitors: A Meta-Analysis of Randomized Controlled Trials

Muhammad Yasir Anwar, Unaiza Faizan, MD, Muhammad Khawar Sana, MD, Muhammad Ans Sharif, MBBS, Ali Anjum, MD, Hafsa Tahir Chaudry, MBBS, Sara Ashraf, MD, Muhammad Ashar Ali, MD, Arshia Akbar, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-136972

Published: 2020

Journal Articles

Safety and Efficacy of Ruxolitinib in Steroid-Resistant Graft Versus Host Disease: A Systematic Review and Meta-Analysis

Rimsha Ali, Muhammad Ashar Ali, MD, Taaha Muddassir Mirza, MBBS, Aqsa Mumtaz, MBBS, Farwah N. Fatima, MBBS, Nayab Mirza, MD, Sana Khan, MBBS, Wajeeha Aiman, MD, Anum Javaid, MD, Muhammad Yasir Anwar, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-137485

Published: 2020

NARROW

Evaluating Daratumumab Effectiveness in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis of Clinical Outcomes and Prognostic Indicators

Comparison of Drugs Used for Prophylaxis in Hemophilia a or B with Inhibitors: A Systematic Review and Frequentist Network Meta-Analysis of Randomized Clinical Trials

Impact of Daratumumab in Transplant Eligible/Ineligible Patients with Newly Diagnosed Multiple Myeloma: An Updated Meta-Analysis of Phase-III Trials

CAR-T Cell Therapy Vs. Standard of Care for B-Cell Lymphoma: A Systematic Review and Meta- Analysis of Updated Results of Clinical Trials

Efficacy and Safety of Polatuzumab Vedotin in Follicular Lymphoma: A Systematic Review of Clinical Trials

Effectiveness and Tolerability of ICE Combinations in Relapsed/Refractory Hodgkin's Lymphoma; A Systematic Review of Clinical Trials

Efficacy and Safety of FLT-3 Inhibitors in Newly Diagnosed FLT-3 Mutated AML Patients: A Systematic Review of Clinical Trials

Efficacy and Safety of Viral Vector Based Gene Therapy in Patients with Hemophilia a: A Systematic Review

Efficacy and Safety of IDH Inhibitors in AML: A Systematic Review of Clinical Trials

Efficacy and Safety of Nelarabine in Different Age Groups with T-Cell Hematological Malignancies: A Systematic Review of Clinical Trials

Efficacy and Safety of Tyrosine Kinase Inhibitors in the Treatment of Relapsed/Refractory Immune Thrombocytopenia

Efficacy and Safety of Chimeric Antigen Receptor T Cell Therapy in Chronic Lymphocytic Leukemia: A Systematic Review

Efficacy and Safety of Recombinant Thrombombomodulin for the Prophylaxis of Vaso-Occlusive Complications in Allogenic Hematopoietic Stem Cell Transplantation : A Systematic Review and Meta-Analysis

Efficacy and Safety of Amlodipine in Preventing Myocardial Iron Overload in Patients with Transfusion-Dependent Thalassemia Major : A Systematic Review and Meta-Analysis

Anti-Thymocyte Globulin (ATG) for Prophylaxis of Severe Graft Vs. Host Disease after Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis

Safety and Efficacy of Salvage Therapies for Relapse/Refractory AML/MDS after First Allogeneic Hematopoietic Stem Cell Transplant: A Systematic Review

Ixazomib Based Regimens in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials

Efficacy and Safety Profile of Ixazomib Based Regimens in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis of Clinical Trials

Risk of Thyroid Dysfunctions with Use of Immune Checkpoint Inhibitors: A Meta-Analysis of Randomized Controlled Trials

Safety and Efficacy of Ruxolitinib in Steroid-Resistant Graft Versus Host Disease: A Systematic Review and Meta-Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only